Columbia’s Dian Yang is placing CRISPR-based molecular recorders into cancer cells to eavesdrop on cancer evolution and pinpoint when and how cells metastasize.
Misinformation and outdated beliefs about screening tests, treatment options, and effects on sexual health continue to cloud understanding about this disease.
The Columbia community gathered in the Hudson Valley for the eighth annual Velocity: Columbia’s Ride to End Cancer. This year’s event raised more than $1 million and attracted nearly 600 participants.
Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
NewYork-Presbyterian/Columbia University Medical Center has named leading physician-scientist Dr. Gary Schwartz chief of the Division of Hematology/Oncology in the Department of Medicine and associate director for research of its Herbert Irving Comprehensive Cancer Center.
On Saturday, November 16, the Columbia University Department of Surgery hosted Lung Cancer Awareness Day at the medical center campus, in Washington Heights.
In August 2013, a large study published in the Journal of the National Cancer Institute found that following a high quality diet may help to reduce one’s risk for developing pancreatic cancer.
Utilizing the latest techniques in molecular biology and genetics, the married team of Cory Abate-Shen and Michael Shen are tackling metastatic prostate cancer.
Radiation exposure from breast cancer treatment is associated with a small risk of developing heart disease later in life, but the risk is now lower than it was 20 years ago.
Isobel Hoevers has co-founded a line of high-end medical ID jewelry that is both functional and fashionable, with a portion of the profits funding research at the Medical Center.